TOLERANCE INDUCING COMBINATION OF AT LEAST TWO ENDOGENOUS ANTIGENS FOR TREATMENT OF SMS, SLE, IDDM, ETC.

摘要

A new method for the treatment of autoimmune diseases in human patients is disclosed, said method involving the re-balancing of the patient's immune response using specific, functional adjuvant/s and the administration of at least two antigens associated with the disease to be treated. Accordingly, a new composition is disclosed, said composition comprising at least antigens together with a functional adjuvant, capable of re-balancing the immune response in relation to the response, typical for the disease to be treated.